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The pluripotent state, which is first established in the primitive ectoderm cells of blastocysts, is lost progressively and irreversibly during subsequent development 1 . For example, development of post-implantation epiblast cells from primitive ectoderm involves significant transcriptional and epigenetic changes, including DNA methylation and X chromosome inactivation 2 , which create a robust epigenetic barrier and prevent their reversion to a primitive-ectoderm-like state. Epiblast cells are refractory to leukaemia inhibitory factor (LIF)-STAT3 signalling, but they respond to activin/basic fibroblast growth factor to form self-renewing epiblast stem cells (EpiSCs), which exhibit essential properties of epiblast cells 3, 4 and that differ from embryonic stem (ES) cells derived from primitive ectoderm 5 . Here we show reprogramming of advanced epiblast cells from embryonic day 5.5-7.5 mouse embryos with uniform expression of N-cadherin and inactive X chromosome to ES-cell-like cells (rESCs) in response to LIF-STAT3 signalling. Cultured epiblast cells overcome the epigenetic barrier progressively as they proceed with the erasure of key properties of epiblast cells, resulting in DNA demethylation, X reactivation and expression of E-cadherin. The accompanying changes in the transcriptome result in a loss of phenotypic and epigenetic memory of epiblast cells. Using this approach, we report reversion of established EpiSCs to rESCs. Moreover, unlike epiblast and EpiSCs, rESCs contribute to somatic tissues and germ cells in chimaeras. Further studies may reveal how signalling-induced epigenetic reprogramming may promote reacquisition of pluripotency.
Previous studies showed that epiblast cells, unlike primitive ectoderm cells, are refractory to LIF-STAT3 signalling; instead they respond to activin/basic fibroblast growth factor (bFGF) to generate EpiSCs 3, 4 , which are more like epiblast with an inactive X chromosome, and differ from ES cells. Here we re-examined advanced post-implantation epiblast cells to see if they could revert to ES-celllike cells in response to LIF-STAT3 signalling.
First, epiblast tissue carrying an Oct4-DPE-green fluorescent protein (GFP) reporter 6 was isolated from mouse embryos on embryonic days (E) E5.5-E7.5. This reporter, with only the distal enhancer for Oct4 (also known as Pou5f1), shows preferential expression in the primitive ectoderm, primordial germ cells (PGCs) and ES cells, but not in the epiblast or EpiSCs 6 . Notably, the distal enhancer constitutes an 'enhanceosome' representing the densest binding locus for the key pluripotency-specific transcripts in ES cells 7 , which makes it likely that its activation will only occur if all pluripotency factors are expressed optimally; some of these must be lacking or suboptimal in the epiblast and EpiSCs.
Next, the epiblast tissue was dissected to remove the most proximal region (the site of existing PGCs and PGC precursors 2 ) and the outer visceral endoderm (Fig. 1a) . Notably, unlike previous studies where the epiblast tissue was left intact 3,4 , we trypsin-digested individual epiblast into a single-cell suspension to break up existing cellcell interactions and promote establishment of a new signallinginduced transcriptional network in vitro. The resulting cells were cultured in LIF-fetal calf serum (FCS) on mouse embryonic fibroblast (MEF) feeder cells, a standard condition used for the derivation of ES cells from primitive ectoderm, and of induced pluripotent stem (iPS) cells from somatic cells 5, 8, 9 . After 4-7 days, most cultures revealed large colonies ( Fig. 1a and Supplementary Table 1) with many alkaline-phosphatase-positive cells (Fig. 1a) , but no detectable Oct4-DPE-GFP expression, indicating that the distal enhancer was yet inactive (Fig. 1a) . We could propagate the cultured epiblast (cEpi) colonies in LIF-FCS after collagenase treatment without detectable changes for at least 20 passages.
After culture of cEpi cells for 14-35 days, we started to detect clusters of GFP-positive cells within cEpi colonies (Fig. 1b, c) , indicating activation of the distal enhanceosome of the Oct4-DPE-GFP reporter 6 . Subsequent culture of GFP-positive cells was carried out after disruption of cEpi colonies by treatment with trypsin, which is detrimental for cEpi cells but promotes propagation of ES-cell-like cells. With further passaging, we established ES-cell-like cells with uniform GFP expression (Fig. 1b) . We call these cells reprogrammed epiblast ES-cell-like cells (rESCs).
The frequency of rESC derivation was relatively high at around 22-36%, which notably did not diminish with developmental age from E5.5 to E7.5 (Supplementary Table 1 ). Furthermore, the epiblast cells at the start were uniformly negative for Oct4-DPE-GFP expression and positive for N-cadherin and inactive X-chromosome (see below). If reversion had occurred from rare epiblast cells, we might have seen a reduction in the frequency of rESC derivation. Notably, no ES-cell-like cells have previously been reported from embryos as late as E7.5; rather, they have only been derived from primitive ectoderm present in the inner cell mass in blastocysts 5, 7, 9 . Furthermore, pluripotent EPL 10 and FAB-SC 11 were derived from pre-implantation or implanting blastocysts and not from post-implantation embryos (Supplementary Table 2 ); their epigenetic state was not reported.
To gain an insight into the reversion process, we examined changes in gene expression (Fig. 2a, b) . Transcriptome analysis revealed that cEpi cells, like EpiSCs 3,4 , were closely related to the epiblast. Thus, cEpi cells showed strong expression of Eomes, Fgf5, Sox17, Gata6, Lefty1 and Cer1. However, there was little expression of stella (also called Dppa3), Pecam1, Rex1 (also called Zfp42) and Fbxo15, but their expression increased in rESCs with a concomitant loss of Fgf5, Eomes and Sox17 (Fig. 2a) . Expression of key pluripotency genes Oct4, Sox2 and Nanog also increased in rESCs ( Fig. 2a and Supplementary Fig. 1 , 2b). Expression of Eomes and Fgf5 was slightly higher in early passage rESCs (passage 4 (P4)) compared to the levels in P24 cells (Fig. 2a) , suggesting a loss of residual 'memory' of their epiblast origin (see below). Thus, comprehensive microarray analysis confirmed that rESCs are similar to ES cells and differ from cEpi cells and EpiSCs ( Fig. 2b and Supplementary Fig. 3 ). These changes in the transcriptome are consistent with the distal enhancer-driven activation of the Oct4-DPE-GFP reporter in rESCs.
We next asked if LIF-STAT3 signalling is critical for reprogramming, and found that STAT3 is phosphorylated in cEpi cells, suggesting that they respond to LIF signalling ( Supplementary Fig. 4a) . Notably, addition of the Janus protein tyrosine kinase inhibitor (JAK inhibitor 1; Calbiochem) that prevents phosphorylation of tyrosine 705 of STAT3 initially allowed some cEpi colonies to develop, but they gradually differentiated and failed to form rESCs (Supplementary Table 3 ). Thus, LIF-STAT3 seems to be crucial for the propagation and reprogramming of cEpi cells to rESCs. Furthermore, culture of rESCs with the JAK inhibitor caused a marked reversal towards the cEpi-like transcriptome ( Supplementary Fig. 4b) . A number of STAT3 targets and their expression have been identified in ES cells 7 , including Fbxo15, Rex1 and Stat3 itself, as well as the epigenetic modifiers Lin28, Ezh2 and Mbd3, suggesting that STAT3 has the potential to influence the transcriptional and epigenetic state of cEpi cells.
Next, we examined epigenetic changes in the epiblast during reversion to rESCs. Notably, reactivation of the late-replicating inactive X chromosome 12, 13 during reversion to rESCs would indicate a major epigenetic change 14 . Consistently, we found that all the E6.5 epiblast cells (96 of 96 cells; Supplementary Fig. 5a ) had the characteristic accumulation of histone H3 lysine 27 trimethylation (H3K27me3) associated with the inactive X chromosome (ref. 15) . After 12 days, nearly all cEpi cells (99 of 100 cells; Fig. 3a ) still had the H3K27me3 'spot', which declined to 62% after 25 days (37 of 60 cells), and to only 9% after 35 days of culture (7 of 80 cells). This suggests continuing epigenetic reprogramming towards rESCs, which uniformly lacked the H3K27me3 'spot'. These observations on H3K27me3 suggest initiation of X reactivation, a hallmark of epigenetic reprogramming, although further studies are needed to confirm completion of the process. Similar changes are also seen after somatic nuclear transplantation into oocytes, in mouse iPS cells, and in ES-cell-somatic cell hybrids [16] [17] [18] [19] . We also examined DNA methylation of the promoter regions of stella and Rex1; both of these genes (and others like Pecam1) are repressed in the epiblast but active in primitive ectoderm and ES cells 20 . Although stella and Rex1 were unmethylated in the epiblast, they became transiently methylated in cEpi cells before undergoing demethylation (Fig. 3b) , which is consistent with the activation of the Stella-GFP reporter in rESCs (Supplementary Fig. 2a ). Once established, the rESC epigenotype was stable, heritable and distinct from EpiSCs, which retain key properties of epiblast cells, including inactive X, and in which stella and Rex1 are methylated and repressed (Figs 2a and 3b) . These findings are relevant to human ES cells, which resemble mouse EpiSCs but not mouse ES cells or rESCs.
To observe the dynamic nature of reprogramming to rESCs, we also examined changes in the expression of E-cadherin and N-cadherin (Fig. 4a) . Whereas expression of both E-cadherin and N-cadherin was detected in E6.5 epiblast uniformly, trypsin-digestion of these cells before culture led to the loss of these adhesion molecules. During subsequent culture, we detected heterogeneous N-cadherin expression in cEpi cells, but in continuing culture there was a complete loss of N-cadherin, which was replaced by uniform expression of E-cadherin in rESCs, consistent with the evidence that LIF-STAT3 promotes upregulation of E-cadherin 11 . Next, we asked if rESCs might have originated from early PGCs because they can undergo dedifferentiation into pluripotent embryonic germ cells that are similar to ES cells. To reduce this likelihood, the epiblast tissue from E6.5-E7.5 mouse embryos was dissected away from the most proximal region, the site of PGC precursors and PGC, respectively. In particular, E7.5 epiblast also shows a loss of competence to form additional PGCs 21 . Second, PGCs require bFGF and stem cell factor for proliferation and dedifferentiation into pluripotent embryonic germ cells, and cannot survive in culture conditions used for cEpi cells. Furthermore, rESCs, unlike embryonic germ cells, retain methylation of imprinted genes 22, 23 ( Supplementary Fig. 5c ). Thus, cumulative evidence makes it unlikely that rESCs could originate from PGCs.
In view of our observations, we asked if established EpiSCs cultured in activin/bFGF could also undergo reversion to rESCs in response to LIF-STAT3. We chose two EpiSC lines: one with the Oct4-DPE-GFP reporter (passage 20) and the other with an X-GFP reporter; the latter was FACS sorted to establish lines with repressed reporter on the inactive X chromosome (passage 23) (Supplementary Fig. 5b ). When these EpiSCs with stably repressed GFP reporters were cultured for 10-20 days (Supplementary Fig. 6a, b) , we detected GFP-positive LETTERS cells, from which we established rESCs as before. Re-expression of the X-GFP reporter indicates X reactivation. Furthermore, we found that the stably repressed stella and Rex1 became de-repressed after DNA demethylation during reversion to rESCs (Figs 2a and 3b) . Thus, unlike previous studies 24, 25 , we found that reversion of EpiSCs is possible in response to LIF-STAT3 without exogenous transcription factors. We had previously shown that ES cells in LIF-FCS exist in a metastable state and fluctuate between ES cell and epiblast-like states but without proceeding completely to the EpiSC-like state. Because the presence of feeder cells apparently helps to promote a shift towards an ES-cell-like state 20 , it is possible that they help to promote the reprogramming process.
Finally, we tested the developmental potential of rESCs in chimaeric embryos. Using rESCs derived from epiblast with the ROSA-LacZ reporter, we found an extensive contribution to developing embryos and in adults with germline transmission (Supplementary Fig. 7 and Supplementary Tables 4-6 ). Although early passage rESCs contributed to the extra-embryonic ectoderm (a trophectoderm derivative) in E6.5 embryos (Supplementary Fig. 7b ), this was not seen with latepassage rESCs (Supplementary Table 6 and Supplementary Fig. 7c ). Thus, a transient memory of the epiblast origin in rESCs is lost with progressive changes in the transcriptome and the epigenetic state. Most notably, rESCs from EpiSCs could also participate in chimaeras and contribute to the germ line in E13.5 embryos ( Supplementary  Fig. 7i and Supplementary Table 5) , which is not possible with EpiSCs 3, 4 , indicating that rESCs derived from EpiSCs undergo a stable reversion to an ES-cell-like state.
Post-implantation epiblast cells and established EpiSCs can 'overcome' a robust epigenetic barrier and undergo reversion to rESCs in response to LIF-STAT3 (Fig. 4b) . This observation is significant for human ES cells, which resemble mouse EpiSCs 3, 4, 26 . Further studies may provide critical insights into signal-induced epigenetic reprogramming, including DNA demethylation and X-reactivation, which also represent a major barrier during reprogramming of somatic cells to iPS cells 9, 20, 27, 28 . Notably, specification of PGCs from epiblast is also accompanied by similar epigenetic reprogramming events by a different mechanism involving the expression of key germ-cell determinants, including Blimp1/Prdm1 and Prdm14 (refs 2, 21); these genes repress the somatic program and initiate epigenetic reprogramming during specification of PGCs from epiblast cells 29 . As a result, PGCs are epigenetically similar to primitive ectoderm cells (Fig. 4b, refs 29-31 ). Epigenetic changes in PGCs, and during the experimental reversion of epiblast and EpiSCs to rESCs, may provide novel insights into diverse mechanisms underlying epigenetic reprogramming of epiblast cells, and contribute generally to the understanding of the role of epigenetic mechanisms in other contexts. 
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